Detalhe da pesquisa
1.
Dickkopf-1 directs periosteal bone formation in two murine models of inflammatory arthritis.
Scand J Rheumatol
; 51(6): 495-499, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35272576
2.
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs.
Ann Oncol
; 32(5): 620-630, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639216
3.
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study.
Ann Oncol
; 31(8): 1056-1064, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418886
4.
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50.
Ann Oncol
; 31(3): 404-411, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067682
5.
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
Ann Oncol
; 30(7): 1121-1126, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30980071
6.
Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study.
Ann Oncol
; 30(2): 325-331, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30624546
7.
Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancer.
Ann Oncol
; 29(9): 1964-1971, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30010763
8.
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions.
Ann Oncol
; 29(10): 2092-2097, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30351341
9.
Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study.
Ann Oncol
; 29(11): 2214-2222, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30215676
10.
Crizotinib resistance: implications for therapeutic strategies.
Ann Oncol
; 27 Suppl 3: iii42-iii50, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573756
11.
Inflammation in arthritis induces expression of BMP3, an inhibitor of bone formation.
Scand J Rheumatol
; 45(5): 379-83, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26982203
12.
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer.
Br J Cancer
; 113(2): 199-203, 2015 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26125448
13.
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer.
Ann Oncol
; 24(1): 59-66, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22887466
14.
Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study.
ESMO Open
; 7(1): 100342, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34896762
15.
Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study.
Lung Cancer
; 163: 7-13, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890832
16.
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.
NPJ Precis Oncol
; 6(1): 13, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233056
17.
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.
Ann Oncol
; 22(12): 2616-2624, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22071650
18.
Optimizing treatment for patients with anaplastic lymphoma kinase-positive lung cancer.
Clin Pharmacol Ther
; 101(5): 625-633, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28182271
19.
Current status of targeted therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer.
Clin Pharmacol Ther
; 95(1): 15-23, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24091716
20.
Mouse models of human non-small-cell lung cancer: raising the bar.
Cold Spring Harb Symp Quant Biol
; 70: 241-50, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16869760